Zenith Drugs Limited — Others, 12-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Zenith Drugs Limited has announced a board meeting to discuss the financial results for the quarter and half-year ending March 31, 2025. The company has received a compliance certificate from Bigshare Services confirming that all shares are held in demat form, with no requests for rematerialization during the quarter. This highlights efficient management of shareholding and regulatory compliance.

Investors may view this update positively, as it indicates stability in the company's operations and adherence to governance norms, potentially enhancing shareholder confidence.